A carregar...
Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
INTRODUCTION: Patients with type 2 diabetes mellitus (T2DM) who fail to meet glycaemic control are at increased risk of diabetes complications. For patients who cannot maintain glycaemic control with oral medication, one recommended option is to add an injectable glucagon-like peptide-1 receptor ago...
Na minha lista:
| Publicado no: | Drugs R D |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6544605/ https://ncbi.nlm.nih.gov/pubmed/31115873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-019-0273-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|